midazolam and pemetrexed

midazolam has been researched along with pemetrexed in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Buie, L; Chiu, WK; Davies, J; Dees, EC; Ivanova, A; Keller, K; O'Neil, B; Sanoff, HK; Stinchcombe, TE; Walko, C	1

Reviews

1 review(s) available for midazolam and pemetrexed

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for midazolam and pemetrexed

Article	Year
Phase I trial of vinflunine and pemetrexed in refractory solid tumors. Investigational new drugs, 2011, Volume: 29, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Glutamates; Guanine; Humans; Male; Midazolam; Middle Aged; Neoplasms; Pemetrexed; Phenotype; Statistics, Nonparametric; Treatment Outcome; Vinblastine	2011

Article

Year

Phase I trial of vinflunine and pemetrexed in refractory solid tumors.

Investigational new drugs, 2011, Volume: 29, Issue:1

Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Glutamates; Guanine; Humans; Male; Midazolam; Middle Aged; Neoplasms; Pemetrexed; Phenotype; Statistics, Nonparametric; Treatment Outcome; Vinblastine

2011